Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-000817

ACURA PHARMACEUTICALS, INC · ACUR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 3, 2017
Accepted (ET)
Jan 4, 2017 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3,F4Jan 3, 2017M13,216—A28,345D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F2,F6,F5—Jan 3, 2017D8,810D——Common Stock8,81013,216D
Restricted Stock UnitsF4,F2,F5—Jan 3, 2017M13,216D——Common Stock13,2160D
Restricted Stock UnitsF8,F2,F7—Jan 3, 2017A59,523A——Common Stock59,52359,523D

Explanation of responses